Crocin Suppresses Constitutively Active STAT3 Through Induction of Protein Tyrosine Phosphatase SHP-1

Buyun Kim1, Ki Yong Lee2, Byoungduck Park1

  • 1College of Pharmacy, Keimyung University, 1095 Dalgubeoldaero, Dalseo-Gu, Daegu 704-701, Republic of Korea.

Insights

Crocin, a saffron compound, inhibits STAT3 activation in multiple myeloma cells by targeting key kinases and phosphatases. This natural compound shows potential for preventing and treating multiple myeloma.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Multiple myeloma is a hematological malignancy characterized by uncontrolled proliferation of plasma cells.
  • Constitutive activation of the STAT3 signaling pathway is frequently observed in multiple myeloma and contributes to tumor growth and survival.

Purpose of the Study:

  • To investigate the effect of crocin, a natural compound from saffron, on STAT3 activation in human multiple myeloma cells.
  • To elucidate the molecular mechanisms underlying crocin's action on the STAT3 pathway.

Main Methods:

  • Crocin treatment of human multiple myeloma cells.
  • Western blot analysis to assess protein expression and activation (STAT3, JAK1, JAK2, c-Src, SHP-1).
  • Quantitative real-time PCR to evaluate target gene expression.
  • Flow cytometry to analyze cell cycle distribution and apoptosis.

Main Results:

  • Crocin suppressed STAT3 activation, nuclear translocation, and target gene expression in multiple myeloma cells.
  • Crocin's effect was mediated by inhibiting JAK1, JAK2, and c-Src kinases and inducing SHP-1 phosphatase.
  • Crocin downregulated STAT3-regulated genes involved in apoptosis, invasion, angiogenesis, and cell cycle progression, leading to reduced proliferation and induced apoptosis.

Conclusions:

  • Crocin acts as a novel inhibitor of the STAT3 activation pathway.
  • Crocin demonstrates potential therapeutic value for the prevention and treatment of human multiple myeloma.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.5K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.9K